Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.

Sasabe N, Keyamura Y, Obama T, Inoue N, Masuko Y, Igarashi Y, Aiuchi T, Kato R, Yamaguchi T, Kuwata H, Iwamoto S, Miyazaki A, Hara S, Yoshikawa T, Itabe H.

Lipids Health Dis. 2014 Mar 14;13:48. doi: 10.1186/1476-511X-13-48.

2.

Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.

Subramanian VS, Goyal J, Miwa M, Sugatami J, Akiyama M, Liu M, Subbaiah PV.

Biochim Biophys Acta. 1999 Jul 9;1439(1):95-109.

PMID:
10395969
4.

Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.

Itabe H, Suzuki K, Tsukamoto Y, Komatsu R, Ueda M, Mori M, Higashi Y, Takano T.

Biochim Biophys Acta. 2000 Sep 27;1487(2-3):233-45.

PMID:
11018475
5.
6.

Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.

Itabe H, Yamamoto H, Suzuki M, Kawai Y, Nakagawa Y, Suzuki A, Imanaka T, Takano T.

J Biol Chem. 1996 Dec 27;271(52):33208-17.

7.

Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein.

Davis B, Koster G, Douet LJ, Scigelova M, Woffendin G, Ward JM, Smith A, Humphries J, Burnand KG, Macphee CH, Postle AD.

J Biol Chem. 2008 Mar 7;283(10):6428-37. doi: 10.1074/jbc.M709970200.

8.
9.

Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids.

Choi J, Zhang W, Gu X, Chen X, Hong L, Laird JM, Salomon RG.

Chem Res Toxicol. 2011 Jan 14;24(1):111-8. doi: 10.1021/tx100305b.

10.

Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.

Liapikos TA, Antonopoulou S, Karabina SP, Tsoukatos DC, Demopoulos CA, Tselepis AD.

Biochim Biophys Acta. 1994 Jun 2;1212(3):353-60.

PMID:
8199206
11.

LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.

Schnitzer E, Pinchuk I, Fainaru M, Lichtenberg D, Yedgar S.

Free Radic Biol Med. 1998 May;24(7-8):1294-303.

PMID:
9626586
12.

Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation.

Chen L, Liang B, Froese DE, Liu S, Wong JT, Tran K, Hatch GM, Mymin D, Kroeger EA, Man RY, Choy PC.

J Lipid Res. 1997 Mar;38(3):546-53.

13.

Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.

Marathe GK, Davies SS, Harrison KA, Silva AR, Murphy RC, Castro-Faria-Neto H, Prescott SM, Zimmerman GA, McIntyre TM.

J Biol Chem. 1999 Oct 1;274(40):28395-404.

14.

In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.

Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K, Nagai R, Horiuchi S, Itabe H, Takano T.

Atherosclerosis. 2000 Jun;150(2):343-55.

PMID:
10856526
15.

PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.

Karabina SA, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD.

Atherosclerosis. 1996 Aug 23;125(1):121-34.

PMID:
8831934
16.

A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein.

Martens JS, Lougheed M, Gómez-Muñoz A, Steinbrecher UP.

J Biol Chem. 1999 Apr 16;274(16):10903-10.

17.

Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability.

Kotosai M, Shimada S, Kanda M, Matsuda N, Sekido K, Shimizu Y, Tokumura A, Nakamura T, Murota K, Kawai Y, Terao J.

Lipids. 2013 Jun;48(6):569-78. doi: 10.1007/s11745-013-3779-1.

18.

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA.

J Clin Invest. 1995 Feb;95(2):774-82.

19.

Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.

Noto H, Hara M, Karasawa K, Iso-O N, Satoh H, Togo M, Hashimoto Y, Yamada Y, Kosaka T, Kawamura M, Kimura S, Tsukamoto K.

Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):829-35.

20.

Human native, enzymatically modified and oxidized low density lipoproteins show different lipidomic pattern.

Orsó E, Matysik S, Grandl M, Liebisch G, Schmitz G.

Biochim Biophys Acta. 2015 Mar;1851(3):299-306. doi: 10.1016/j.bbalip.2015.01.001.

PMID:
25583048
Items per page

Supplemental Content

Support Center